Omada Health

NASDAQ:OMDA

Medical - Healthcare Information Services

Healthcare
$13.17 +0.78%

+$0.13 today

Market cap
$817.04M
Beta
2.09
P/E (TTM)
-162.6
EPS (TTM)
-$0.11
52W Low $10.28High $26.92

Volume 1.68M

Average 1.07M

OMDA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Omada HealthNASDAQ: OMDA

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 62.4%

Gross margin was 62.4% in Q1 FY2026, up 4.3 pp from a year earlier. On a trailing-twelve-month basis it was 66.2%, up 4.6 pp year over year. Over 3 fiscal years it widened by 17.7 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
62.4%-8.4 pp QoQ
Last fiscal yearDec 2025
65.7%+5.1 pp YoY
LTMMar 2026
66.2%+4.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.3 pp——
1 year+5.1 pp——
3 years+17.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
65.7%
Year-over-year change
+5.1pp

Gross Margin vs competitors

How OMDA compares with its peers on the latest reported figures

  • OMDA's LTM Mar 2026 gross margin of 66.2% is the 2nd highest of the 5 companies compared; the peer median is 63.0%.
  • Its year-over-year change of +4.6 pp is the 3rd highest of 5, against a peer median of +0.3 pp.
  • Over three fiscal years its change of +17.7 pp compares with a peer median of +0.4 pp.
OMDA Competitors Peer median
Gross Margin for OMDA and competitors
Company Period LTM level YoY 3-year change
HNGEHinge Health, Inc.LTM Jun 202684.5% +6.9 pp—
OMDAOmada HealthLTM Mar 202666.2% +4.6 pp+17.7 pp
TDOCTeladoc Health, Inc.LTM Mar 202665.6% -4.9 pp+0.4 pp
HIMSHims & Hers Health, Inc.LTM Sep 202660.5% -14.6 pp-3.7 pp
AMWLAmerican Well CorporationLTM Mar 202649.7% +5.4 pp+11.2 pp
Peer median (excluding OMDA) 63.0%+0.3 pp+0.4 pp

Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue89.19M122.78M169.8M260.21M
Cost of Revenue46.39M52.81M66.92M89.27M
Gross Profit42.79M69.97M102.88M170.94M
Gross Margin48.0%57.0%60.6%65.7%
Research & Development26.17M33.74M35.92M40.68M
Selling, General & Admin88.97M102.23M110.61M142.23M
Operating Expenses115.14M135.97M146.53M182.91M
Depreciation & Amortization4.33M4.45M4.8M5.49M
EBITDA(63.99M)(58.36M)(37.83M)(4.75M)
EBITDA Margin-71.7%-47.5%-22.3%-1.8%
Operating Income(72.35M)(66M)(43.65M)(11.97M)
Operating Margin-81.1%-53.8%-25.7%-4.6%
Interest Income2.2M5.78M805K5.31M
Interest Expense4.2M4.71M4.51M2.53M
Other Income / Expenses(168K)(1.51M)(3.48M)(806K)
Income Before Tax(72.52M)(67.51M)(47.14M)(12.78M)
Pre-Tax Margin-81.3%-55.0%-27.8%-4.9%
Income Tax Expense0000
Net Income(72.52M)(67.51M)(47.14M)(12.78M)
Net Margin-81.3%-55.0%-27.8%-4.9%
EPS (Basic)(1.30)(1.21)(0.85)(0.22)
EPS (Diluted)(1.30)(1.21)(0.85)(0.22)
Weighted Avg Shares55.74M55.74M55.74M58.43M
Weighted Avg Shares (Diluted)55.74M55.74M55.74M58.43M

Omada Health

NASDAQ:OMDA

Intrinsic Alpha fair value

Locked

Current Price

$13.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.